Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...

Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their ...

Witty's comments came during the company's first earnings call since the killing of Brian Thompson, the CEO of the company's insurance arm UnitedHealthcare.

Providers, patients and even some federal judges say progress-based insurance denials harm patients at key moments of mental ...

UnitedHealth Group Incorporated (NYSE:UNH) dropped its share prices by 6.04 percent on Thursday to end at $510.59 apiece ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...

Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

According to FTC’s latest report, units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

Our narrow economic moat rating for UnitedHealth Group reflects our generally narrow-moat view of the US health insurance and PBM industries that includes an unclear outlook for economic profitability ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...